Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.
2.

Paroxetine controlled release for premenstrual dysphoric disorder: a double-blind, placebo-controlled trial.

Cohen LS, Soares CN, Yonkers KA, Bellew KM, Bridges IM, Steiner M.

Psychosom Med. 2004 Sep-Oct;66(5):707-13.

PMID:
15385695
3.

Luteal phase administration of paroxetine for the treatment of premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled trial in Canadian women.

Steiner M, Ravindran AV, LeMelledo JM, Carter D, Huang JO, Anonychuk AM, Simpson SD.

J Clin Psychiatry. 2008 Jun;69(6):991-8.

PMID:
18517289
4.

Luteal phase dosing with paroxetine controlled release (CR) in the treatment of premenstrual dysphoric disorder.

Steiner M, Hirschberg AL, Bergeron R, Holland F, Gee MD, Van Erp E.

Am J Obstet Gynecol. 2005 Aug;193(2):352-60.

PMID:
16098854
5.

Low doses of controlled-release paroxetine in the treatment of late-life depression: a randomized, placebo-controlled trial.

Rapaport MH, Lydiard RB, Pitts CD, Schaefer D, Bartolic EI, Iyengar M, Carfagno M, Lipschitz A.

J Clin Psychiatry. 2009 Jan;70(1):46-57.

PMID:
19026248
7.

Paroxetine controlled release.

Bang LM, Keating GM.

CNS Drugs. 2004;18(6):355-64; discussion 365-6. Review.

PMID:
15089103
8.

Symptom-onset treatment for women with premenstrual dysphoric disorder.

Yonkers KA, Holthausen GA, Poschman K, Howell HB.

J Clin Psychopharmacol. 2006 Apr;26(2):198-202.

PMID:
16633152
9.

A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder.

Pollack M, Mangano R, Entsuah R, Tzanis E, Simon NM, Zhang Y.

Psychopharmacology (Berl). 2007 Oct;194(2):233-42. Erratum in: Psychopharmacology (Berl). 2008 Feb;196(2):339. Zhang, Ying [added].

PMID:
17589833
10.
11.

Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Perahia DG, Wang F, Mallinckrodt CH, Walker DJ, Detke MJ.

Eur Psychiatry. 2006 Sep;21(6):367-78.

PMID:
16697153
12.

Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder.

Landén M, Nissbrandt H, Allgulander C, Sörvik K, Ysander C, Eriksson E.

Neuropsychopharmacology. 2007 Jan;32(1):153-61.

14.
15.

A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.

Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.

Depress Anxiety. 2007;24(1):1-14.

PMID:
16894619
16.

A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.

Musselman DL, Somerset WI, Guo Y, Manatunga AK, Porter M, Penna S, Lewison B, Goodkin R, Lawson K, Lawson D, Evans DL, Nemeroff CB.

J Clin Psychiatry. 2006 Feb;67(2):288-96.

PMID:
16566626
17.
18.

A randomized, controlled, trial of controlled release paroxetine in fibromyalgia.

Patkar AA, Masand PS, Krulewicz S, Mannelli P, Peindl K, Beebe KL, Jiang W.

Am J Med. 2007 May;120(5):448-54.

PMID:
17466657
19.

Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder.

Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A.

Obstet Gynecol. 2005 Sep;106(3):492-501.

PMID:
16135578
20.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Review. French.

PMID:
18922243
Items per page

Supplemental Content

Support Center